Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Solid Tumors
Interventions: DRUG: triacetyluridine|DRUG: fluorouracil|DRUG: leucovorin|DRUG: camptosar
Sponsor: Wellstat Therapeutics